Juvenile Rheumatoid Arthritis Research Registry
NCT00090571 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2022-09-28
Summary
Juvenile rheumatoid arthritis (JRA) is the most common chronic inflammatory disease in children, and may be related to genetics. Having two siblings who both have JRA in one family is rare. The purpose of this registry is to collect patient information and blood samples from qualifying JRA siblings and their families. The goal of the registry is to further understanding of JRA as related to genetics.
Conditions
- Juvenile Rheumatoid Arthritis
Sponsors & Collaborators
-
Children's Hospital Medical Center, Cincinnati
collaborator OTHER -
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
lead NIH
Principal Investigators
-
David N. Glass, MD · Children's Hospital Medical Center, Cincinnati
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 1994-10-31
- Primary Completion
- 2009-09-30
- Completion
- 2009-09-30
Countries
- United States
Study Locations
More Related Trials
-
Study of Methotrexate Given to Juvenile Idiopathic Arthritis Patients Based on Pharmacogenomics and Pharmacometrics
NCT03006991 ·Status: UNKNOWN
-
Juvenile Arthritis Quantitative Imaging
NCT02684695 ·Status: RECRUITING
-
Pharmacokinetics Of CP-690,550 In Pediatric Patients With Juvenile Idiopathic Arthritis (JIA)
NCT01513902 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacovigilance in Juvenile Idiopathic Arthritis Patients Treated With Biologic Agents and/or Methotrexate
NCT01399281 ·Status: UNKNOWN
-
To Investigate Genetic Factors Associated With the Response to Anti-TNF Therapy in Patients With Early AS
NCT02311842 ·Status: COMPLETED
-
Relation of IL23R and IL17A Gene Polymorphisms Plus Serum Levels of IL23 and IL17A to Rheumatoid Arthritis Susceptibility and Activity
NCT05570513 ·Status: NOT_YET_RECRUITING
-
Angiogenic Biomarkers in Juvenile Idiopathic Arthritis
NCT05534347 ·Status: RECRUITING
-
Kineret in the Treatment of Rheumatoid Arthritis
NCT02915094 ·Status: COMPLETED
-
Empowering Physicians With Evidence-Based Decision Support for Pediatric Rheumatology
NCT02205086 ·Status: UNKNOWN ·Phase: NA
-
Study of Human Leukocyte Antigen (HLA) Polymorphisms in Patients With Rheumatoid Arthritis
NCT01111357 ·Status: COMPLETED
-
An Open-label Extension Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis and Active Systemic Manifestations Manifestations and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever.
NCT00891046 ·Status: COMPLETED ·Phase: PHASE3
-
Long-term Safety Study of Kineret® in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA)
NCT03932344 ·Status: COMPLETED
-
UCAN CAN-DU: Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Disease
NCT06560606 ·Status: RECRUITING
-
CorEvitas Rheumatoid Arthritis (RA) Drug Safety & Effectiveness Registry
NCT01402661 ·Status: ENROLLING_BY_INVITATION
-
An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis
NCT01357668 ·Status: ACTIVE_NOT_RECRUITING
-
Registry of Etanercept (Enbrel®) In Children With Juvenile Rheumatoid Arthritis
NCT00078793 ·Status: COMPLETED
-
Network to Understand Reproductive Rheumatology Registry
NCT06940869 ·Status: ENROLLING_BY_INVITATION
-
Study of Gammalinolenic Acid for Juvenile Rheumatoid Arthritis
NCT00004420 ·Status: COMPLETED ·Phase: NA
-
Patient Centered Adaptive Treatment Strategies Using Bayesian Causal Inference
NCT02524340 ·Status: COMPLETED
-
Juvenile Rheumatoid Arthritis
NCT00037648 ·Status: COMPLETED ·Phase: PHASE2
-
Study During Pregnancy of Expression of miRNAs in RA or SLE
NCT02350491 ·Status: COMPLETED
-
Study To Determine The Pharmacokinetics Of Sulfasalazine In Children With Juvenile Idiopathic Arthritis
NCT00637780 ·Status: TERMINATED ·Phase: PHASE4
-
Single-dose Study to Assess Efficacy of Canakinumab (ACZ885) in Patients With Active Juvenile Idiopathic Arthritis (SJIA)
NCT00886769 ·Status: TERMINATED ·Phase: PHASE3
-
NFKB1 and IKK Epsilon in Rheumatoid Arthritis
NCT02689115 ·Status: COMPLETED
-
Rheumatology Clinical Registry
NCT01813409 ·Status: UNKNOWN